u/MaterialPhysical1030

https://ca.finance.yahoo.com/news/ataibeckley-atai-reports-q1-financial-184349221.html

https://ca.finance.yahoo.com/news/definium-therapeutics-announces-employee-inducement-200100142.html

https://ca.finance.yahoo.com/news/compass-pathways-announces-employee-inducement-102500633.html

https://ca.finance.yahoo.com/video/medpal-ai-futura-medical-solvonis-085900905.html

Solvonis Therapeutics PLC (LSE:SVNS) is pushing its alcohol use disorder drug SVN-001 into phase III trials rather than doing an early licensing deal. The board thinks the asset is worth more after a successful trial than before one.

https://ca.finance.yahoo.com/news/does-robert-langer-arrival-reframe-120533038.html